BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18663099)

  • 1. Get with the (re)program: cardiovascular potential of skin-derived induced pluripotent stem cells.
    Tulloch NL; Pabon L; Murry CE
    Circulation; 2008 Jul; 118(5):472-5. PubMed ID: 18663099
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspective from the heart: the potential of human pluripotent stem cell-derived cardiomyocytes.
    Xu XQ; Sun W
    J Cell Biochem; 2013 Jan; 114(1):39-46. PubMed ID: 22903726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation, expansion, and differentiation of cardiovascular progenitor cells from human pluripotent stem cells.
    Cao N; Liang H; Yang HT
    Methods Mol Biol; 2015; 1212():113-25. PubMed ID: 25208753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluripotent stem cell derived cardiovascular progenitors--a developmental perspective.
    Birket MJ; Mummery CL
    Dev Biol; 2015 Apr; 400(2):169-79. PubMed ID: 25624264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells.
    Narazaki G; Uosaki H; Teranishi M; Okita K; Kim B; Matsuoka S; Yamanaka S; Yamashita JK
    Circulation; 2008 Jul; 118(5):498-506. PubMed ID: 18625891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
    Murata M; Tohyama S; Fukuda K
    Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells for the study of cardiovascular disease.
    Savla JJ; Nelson BC; Perry CN; Adler ED
    J Am Coll Cardiol; 2014 Aug; 64(5):512-9. PubMed ID: 25082586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells.
    Lu TY; Lin B; Kim J; Sullivan M; Tobita K; Salama G; Yang L
    Nat Commun; 2013; 4():2307. PubMed ID: 23942048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells.
    Xu C
    J Mol Cell Cardiol; 2012 Jun; 52(6):1203-12. PubMed ID: 22484618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.
    Freund C; Mummery CL
    J Cell Biochem; 2009 Jul; 107(4):592-9. PubMed ID: 19449339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocytes derived from pluripotent stem cells: progress and prospects from China.
    Yang HT; Zhang M; Huang J; Liang H; Zhang P; Boheler KR
    Exp Cell Res; 2013 Jan; 319(2):120-5. PubMed ID: 23022397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte differentiation of human induced pluripotent stem cells.
    Zwi L; Caspi O; Arbel G; Huber I; Gepstein A; Park IH; Gepstein L
    Circulation; 2009 Oct; 120(15):1513-23. PubMed ID: 19786631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Review of basic studies about the cardiac stem cell and regenerative medicine].
    Tamura Y; Fukuda K
    Nihon Rinsho; 2008 May; 66(5):908-14. PubMed ID: 18464509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation of human induced pluripotent stem cells for cardiovascular disease modeling.
    Narsinh K; Narsinh KH; Wu JC
    Circ Res; 2011 Apr; 108(9):1146-56. PubMed ID: 21527744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial and cardiac progenitors: boosting, conditioning and (re)programming for cardiovascular repair.
    Pesce M; Burba I; Gambini E; Prandi F; Pompilio G; Capogrossi MC
    Pharmacol Ther; 2011 Jan; 129(1):50-61. PubMed ID: 21035506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human stem cell-derived cardiomyocytes for pharmacological and toxicological modeling.
    Harding SE
    Ann N Y Acad Sci; 2011 Dec; 1245():48-9. PubMed ID: 22211978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyocytes derived from human pluripotent stem cells for drug screening.
    Zeevi-Levin N; Itskovitz-Eldor J; Binah O
    Pharmacol Ther; 2012 May; 134(2):180-8. PubMed ID: 22269465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iPS cells: a source of cardiac regeneration.
    Yoshida Y; Yamanaka S
    J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.
    Dambrot C; Passier R; Atsma D; Mummery CL
    Biochem J; 2011 Feb; 434(1):25-35. PubMed ID: 21269276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pluripotent stem cells: a cell model for early cardiac development].
    Pucéat M
    Biol Aujourdhui; 2012; 206(1):25-9. PubMed ID: 22463993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.